1986Scandinavian Journal of GastroenterologyRequires access

Short-Term Treatment of Gastric Ulcer with Once Daily Omeprazole

W Hütemann

Open publisher page 10 citations

Abstract

Omeprazole, at present the only substituted benzimidazole in clinical evaluation for the treatment of acid related diseases, shows a novel mechanism of action. It interferes with the proton pump in the secretory membrane of the parietal cell, the H+K+ATPase, an enzyme unique to the gastric mucosa (1). Due to its potent and long lasting antisecretory activity, omeprazole may be used in a once daily regimen for ulcer therapy. Omeprazole is the only anti-secretory drug known to reduce gastric acidity during both the day and the night, by almost 100% and 85% respectively (2, 3). While very high 14-day healing rates can be achieved in duodenal ulcer disease (4–6), nothing is known of the efficacy of omeprazole in the treatment of gastric ulcer.

About this research paper

What this paper is about

Omeprazole, at present the only substituted benzimidazole in clinical evaluation for the treatment of acid related diseases, shows a novel mechanism of action. It interferes with the proton pump in the secretory membrane of the parietal cell, the H+K+ATPase, an enzyme unique to the gastric mucosa (1). Due to its potent and long lasting antisecretory activity, omeprazole may be used in a once daily regimen for ulcer therapy. Omeprazole is the only anti-secretory drug known to reduce gastric acidity during both the day and the night, by almost 100% and 85% respectively (2, 3). While very high 14-day healing rates can be achieved in duodenal ulcer disease (4–6), nothing is known of the efficacy of omeprazole in the treatment of gastric ulcer.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Omeprazole, at present the only substituted benzimidazole in clinical evaluation for the treatment of acid related diseases, shows a novel mechanism of action. It interferes with the proton pump in the secretory membrane of the parietal cell, the H+K+ATPase, an enzyme unique to the gastric mucosa (1). Due to its potent and long lasting antisecretory activity, omeprazole may be used in a once daily regimen for ulcer therapy. Omeprazole is the only anti-secretory drug known to reduce gastric acidity during both the day and the night, by almost 100% and 85% respectively (2, 3). While very high 14-day healing rates can be achieved in duodenal ulcer disease (4–6), nothing is known of the efficacy of omeprazole in the treatment of gastric ulcer.

Key concepts: Omeprazole, Parietal cell, Gastroenterology, Gastric acid, Medicine, Internal medicine, Proton-pump inhibitor, Proton pump

Related papers

Back to paper searchBrowse research topicsOriginal source
Short-Term Treatment of Gastric Ulcer with Once Daily Omeprazole — Research Paper | ScholarLens